| Literature DB >> 25852150 |
Shuqi Jiang1, Xianrong Shen2, Yuming Liu3, Ying He3, Dingwen Jiang3, Wei Chen3.
Abstract
This study investigated the radioprotective effect of Sipunculus nudus L. polysaccharide (SNP) in combination with WR-2721, rhIL-11 and rhG-CSF on irradiated mice. A total of 70 Imprinting Control Region (ICR) mice were divided into seven groups: the control group, the model group and five administration groups. All groups, except the control group, were exposed to a 5 Gy (60)Co γ-ray beam. Blood parameters [including white blood cell (WBC), red blood cell (RBC) and platelet counts and hemoglobin level] were assessed three days before irradiation, and the on the 3rd, 7th and 14th days after irradiation. Spleen, thymus and testicular indices, DNA contents of bone marrow cells, bone marrow nucleated cells, sperm counts, superoxide dismutase (SOD), malondialdehyde (MDA), testosterone and estradiol levels in the serum were assessed on the 14th day after irradiation. The combined administration of SNP, WR-2721, rhIL-11 and rhG-CSF exerted synergistic recovery effects on peripheral blood WBC, RBC and platelet counts and hemoglobin levels in irradiated mice, and synergistic promotion effects on spleen, thymus, testicle, bone marrow nucleated cells and sperm counts in irradiated mice. The synergistic administration increased the serum SOD activities and serum testosterone content of irradiated mice, but synergy decreased the content of serum MDA and estradiol in irradiated mice. These results suggest that the combined administration of SNP, WR-2721, rhIL-11 and rhG-CSF should increase the efficacy of these drugs for acute radiation sickness, protect immunity, hematopoiesis and the reproductive organs of irradiated-damaged mice, and improve oxidation resistance in the body.Entities:
Keywords: Sipunculus nudus L. polysaccharide; WR-2721; combination administration; radioprotection; rhG-CSF; rhIL-11
Mesh:
Substances:
Year: 2015 PMID: 25852150 PMCID: PMC4426933 DOI: 10.1093/jrr/rrv009
Source DB: PubMed Journal: J Radiat Res ISSN: 0449-3060 Impact factor: 2.724
Administration techniques and doses for each group of ICR mice
| Group | Administration and dose |
|---|---|
| Control group | 0.2 ml/0.02 kg H2O intragastrically once daily |
| Model group | 0.2 ml/0.02 kg H2O intragastrically once daily |
| W group | 400 mg/kg WR-2721 intraperitoneally 30 min before irradiation |
| S + I + G group | 400 mg/kg SNP intragastrically once daily, and 200 μg/kg rhIL-11 and 30 μg/kg rhG-CSF subcutaneously once daily for 7 days after irradiation |
| S + W group | 400 mg/kg SNP intragastrically once daily, and 400 mg/kg WR-2721 intraperitoneally 30 min before irradiation |
| W + I + G group | 400 mg/kg WR-2721 intraperitoneally 30 min before irradiation, and 200 μg/kg rhIL-11 and 30 μg/kg rhG-CSF subcutaneously once daily for 7 days after irradiation |
| S + W + I + G group | 400 mg/kg SNP intragastrically once daily, and 400 mg/kg WR-2721 intraperitoneally 30 min before irradiation, and 200 μg/kg rhIL-11 and 30 μg/kg rhG-CSF subcutaneously once daily for 7 days after irradiation |
Peripheral blood WBC counts in experimental mice (mean ± SD, × 109·l−1)
| Group | 3 Days before IR | Day 3 after IR | Day 7 after IR | Day 14 after IR |
|---|---|---|---|---|
| Control group | 7.1 ± 1.2 | 11.3 ± 1.6 | 17.0 ± 4.5 | 14.8 ± 3.9 |
| Model group | 7.2 ± 0.9 | 1.3 ± 0.3● | 2.5 ± 1.1● | 5.5 ± 1.6● |
| W group | 7.4 ± 1.2 | 2.1 ± 0.8●* | 5.0 ± 2.2●Δ | 6.5 ± 1.7● |
| S + I + G group | 7.0 ± 1.0 | 1.6 ± 0.3● | 1.9 ± 1.1● | 6.9 ± 2.9● |
| S + W group | 7.2 ± 1.0 | 2.3 ± 0.7●Δ | 5.1 ± 2.9●* | 4.6 ± 1.0● |
| W + I + G group | 7.4 ± 1.3 | 2.7 ± 0.9●Δ | 5.3 ± 2.0●Δ | 5.3 ± 1.5● |
| S + W + I + G group | 7.2 ± 0.9 | 3.0 ± 0.5●Δ | 7.9 ± 2.6●Δ | 9.9 ± 1.4●Δ |
Compared with the control group: closed circle: P < 0.01. Compared with the model group: asterisk: P < 0.05, closed triangle: P < 0.01.
Peripheral blood platelet counts in experimental mice (mean ± SD, × 109·l−1)
| Group | 3 days before IR | Day 3 after IR | Day 7 after IR | Day 14 after IR |
|---|---|---|---|---|
| Control group | 994 ± 104 | 871 ± 100 | 954 ± 128 | 1119 ± 137 |
| Model group | 1032 ± 91 | 933 ± 116 | 459 ± 93● | 810 ± 156● |
| W group | 987 ± 87 | 998 ± 105○ | 545 ± 136● | 841 ± 131● |
| S + I + G group | 1029 ± 102 | 1167 ± 171●Δ | 381 ± 84● | 1016 ± 265 |
| S + W group | 1076 ± 127 | 904 ± 143 | 487 ± 95● | 981 ± 112○ |
| W + I + G group | 1044 ± 145 | 872 ± 87 | 544 ± 75●* | 944 ± 124○ |
| S + W + I + G group | 1128 ± 97 | 968 ± 155 | 579 ± 74●Δ | 1000 ± 201* |
Compared with the control group: open circle: P < 0.05, closed circle: P < 0.01. Compared with the model group: asterisk: P < 0.05, closed triangle: P < 0.01.
Peripheral blood RBC counts in experimental mice (mean ± SD, × 1012·l−1)
| Group | 3 Days before IR | Day 3 after IR | Day 7 after IR | Day 14 after IR |
|---|---|---|---|---|
| Control group | 8.28 ± 0.39 | 7.70 ± 0.94 | 7.83 ± 0.71 | 8.70 ± 0.95 |
| Model group | 8.30 ± 0.59 | 8.56 ± 0.80 | 6.93 ± 0.93○ | 6.17 ± 1.31● |
| W group | 8.39 ± 0.33 | 8.50 ± 0.92 | 7.03 ± 0.79○ | 7.56 ± 0.79○* |
| S + I + G group | 8.69 ± 0.52 | 8.29 ± 0.84 | 5.94 ± 0.88●* | 5.73 ± 0.89● |
| S + W group | 8.95 ± 0.77 | 8.64 ± 1.03 | 7.00 ± 1.77 | 7.30 ± 0.59●* |
| W + I + G group | 8.57 ± 0.37 | 8.28 ± 0.77 | 6.92 ± 0.95○ | 8.42 ± 1.26Δ |
| S + W + I + G group | 9.01 ± 0.28 | 8.32 ± 0.71 | 7.15 ± 0.98 | 8.24 ± 0.74Δ |
Compared with the control group: open circle: P < 0.05, closed circle: P < 0.01. Compared with the model group: asterisk: P < 0.05, closed triangle: P < 0.01.
Peripheral blood hemoglobin in experimental mice (mean ± SD, g·L−1)
| Group | 3 Days before IR | Day 3 after IR | Day 7 after IR | Day 14 after IR |
|---|---|---|---|---|
| Control group | 114 ± 9 | 111 ± 14 | 111 ± 7 | 126 ± 9 |
| Model group | 117 ± 9 | 118 ± 9 | 93 ± 14● | 87 ± 18● |
| W group | 115 ± 8 | 119 ± 12 | 98 ± 14○ | 109 ± 8●Δ |
| S + I + G group | 114 ± 9 | 107 ± 9* | 79 ± 11●* | 84 ± 11● |
| S + W group | 114 ± 12 | 125 ± 24 | 94 ± 24○ | 111 ± 10●Δ |
| W + I + G group | 112 ± 8 | 121 ± 6 | 99 ± 13○ | 123 ± 6Δ |
| S + W + I + G group | 114 ± 9 | 123 ± 8○ | 89 ± 19● | 116 ± 3●Δ |
Compared with the control group: open circle: P < 0.05, closed circle: P < 0.01. Compared with the model group: asterisk: P < 0.05, closed triangle: P < 0.01.
Organ indices in experimental mice (mean ± SD)
| Group | Spleen index | Thymus index | Testicle index |
|---|---|---|---|
| Control group | 5.53 ± 2.42 | 1.90 ± 0.40 | 3.10 ± 0.69 |
| Model group | 6.48 ± 2.42 | 1.21 ± 0.27● | 1.99 ± 0.16● |
| W group | 6.56 ± 1.94 | 1.43 ± 0.23○ | 2.08 ± 0.31● |
| S + I + G group | 11.45 ± 2.54●Δ | 1.28 ± 0.32● | 2.36 ± 0.26●* |
| S + W group | 5.87 ± 1.99 | 1.48 ± 0.24○* | 2.64 ± 0.38Δ |
| W + I + G group | 6.71 ± 1.93 | 1.66 ± 0.24Δ | 2.54 ± 0.24Δ |
| S + W + I + G group | 4.89 ± 1.49 | 1.87 ± 0.35Δ | 2.64 ± 0.29Δ |
Compared with the control group: open circle: P < 0.05, closed circle: P < 0.01. Compared with the model group: asterisk: P < 0.05, closed triangle: P < 0.01.
Fig. 1.DNA contents of bone marrow cells in experimental mice. Compared with the control group: open circle: P < 0.05, closed circle: P < 0.01. Compared with the model group: open triangle: P < 0.05, closed triangle: P < 0.01.
Fig. 2.The number of bone marrow nucleated cells in experimental mice. Compared with the control group: open circle: P < 0.05; closed circle: P < 0.01. Compared with the model group: closed triangle: P < 0.01.
Fig. 3.Sperm counts in experimental mice. Compared with the control group: open circle: P < 0.05. Compared with the model group: open triangle: P < 0.05, closed triangle: P < 0.01.
Serum testosterone and estradiol content in experimental mice (mean ± SD)
| Group | Testosterone content (ng·ml−1) | Estradiol content (pmol·l−1) |
|---|---|---|
| Control group | 4.8 ± 0.4 | 12.0 ± 2.3 |
| Model group | 3.7 ± 0.6● | 26.8 ± 2.5● |
| W group | 4.5 ± 0.8* | 15.6 ± 3.9○Δ |
| S + I + G group | 4.6 ± 0.7* | 13.7 ± 2.8Δ |
| S + W group | 5.4 ± 1.1Δ | 13.2 ± 3.9Δ |
| W + I + G group | 4.3 ± 1.2 | 12.9 ± 2.5Δ |
| S + W + I + G group | 6.9 ± 1.5●Δ | 9.2 ± 1.1●Δ |
Compared with the control group: open circle: P < 0.05, closed circle: P < 0.01. Compared with the model group: asterisk: P < 0.05, closed triangle: P < 0.01.
Serum SOD and MDA in experimental mice (mean ± SD)
| Group | SOD (U·ml−1) | MDA (nmol·ml−1) |
|---|---|---|
| Control group | 117.2 ± 9.2 | 7.01 ± 0.89 |
| Model group | 79.5 ± 7.8● | 8.78 ± 0.92● |
| W group | 92.2 ± 6.9●Δ | 8.11 ± 0.44● |
| S + I + G group | 87.8 ± 8.7● | 8.56 ± 1.08○ |
| S + W group | 99.0 ± 6.6●Δ | 8.08 ± 0.93○ |
| W + I + G group | 98.7 ± 11.1●Δ | 7.89 ± 0.67○* |
| S + W + I + G group | 121.4 ± 8.4Δ | 7.49 ± 0.90Δ |
Compared with the control group: open circle: P < 0.05, closed circle: P < 0.01. Compared with the model group: open triangle: P < 0.05, closed triangle: P < 0.01.